Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced or Recurrent Solid Tumors × vadimezan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasm Metastasis 4 Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Unspecified Adult Solid Tumor, Protocol Specific 1 Solid Tumors 1 Solid Tumor Malignancies 1 Prostatic Neoplasms 1 Lung Neoplasms 1 Carcinoma, Transitional Cell 1 Advanced or Recurrent Solid Tumors 1

Interventions

vadimezan 1 tislelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01285453 2020-12-09

Safety and Tolerability of ASA404 Administered in Combination With Docetaxel in Japanese Patients With Solid Tumors

Novartis

Phase 1 Completed

Other solid neoplasm

Advanced or Recurrent Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡